AURA (Aura Biosciences, Inc.) Pangali Forward P/E

Simbol resmi perusahaan Aura Biosciences (AURA)

The market dynamics of the asset help assess the path of Aura Biosciences, Inc. (AURA) toward creating targeted ocular oncology therapy, where the indicator stands at 0.00. The team led by E. Capucci relies on deep scientific expertise and a clear strategic direction. Current business momentum is supported by capital from new investors, as there are no stable profit generators and developments are completing the final stages of testing.

Aura Biosciences - Pangali Forward P/E AURA (periode 04.07.2022 - 18.11.2026)

Ringkesan rincian data analitis Aura Biosciences, Inc. (AURA)

- rega saiki lan proyeksi nilai saham:
Analisis komprehensif perusahaan:Aura Biosciences Inc AURA
Produk merek Aura Corp

Forward P/E determines the value of a single share relative to the projected earnings for the next 12 months. By analyzing the expected NTM P/E of Aura Biosciences, Inc. (AURA), an investor sees the current market valuation of future cash flows. The value 0.00 reflects the premium paid for every dollar of expected income. High metrics are acceptable for Aura Biosciences, Inc. (AURA) due to the exclusivity of VDC technology. The monopoly potential of this eye cancer therapy justifies a premium valuation of its fundamental value.

Analisis perusahaan pesaing

Pangali Forward P/E ONC|HALO (Halozyme Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (revmed.com)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Bio (BCAX) - Rega marang bathi mangsa ngarep|Personalis Corp - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Systems, Inc. DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Corp)|Prakiraan rega marang bathi Candel Therapeutics, Inc. CADL|Pangali Forward P/E ARAY (Accuray, Inc.)|SELLAS Life Sciences - Rega marang bathi mangsa ngarep|ACTU: Prakiraan rega marang bathi|Citius Oncology, Inc. - Rasio kapitalisasi marang bathi mangsa ngarep|HURA (TuHURA Biosciences) - Prakiraan rega marang bathi|TARA: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi FATE|WHWK: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi TCRX (TScan Therapeutics Inc)|Kapitalisasi marang proyeksi bathi Champions Oncology Inc|Pangali Forward P/E XBIT (XBiotech Inc.)|Pangali mangsa ngarep rega marang bathi CVM|OS Therapies Inc. - Pangali Forward P/E|RADX - Pangali Forward P/E|ARTV: Pangali Forward P/E|ANL: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi VERU|TPST: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep xiliotx.com (XLO)|Renovaro - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Mural Oncology MURA|KAPA - Prakiraan rega marang bathi|OKUR - Rega marang bathi mangsa ngarep|GDTC - Pangali Forward P/E|Curis, Inc. (CRIS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Apollomics, Inc.|Prakiraan rega marang bathi THAR|Rasio rega marang bathi mangsa ngarep ADVB (Advanced Biomed)|Prakiraan rega marang bathi GNPX (Genprex, Inc)|CLDI: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep sunshinebiopharma.com SBFM|XBIO - Prakiraan rega marang bathi|SLRX: Prakiraan rega marang bathi|Purple Biotech - Rasio kapitalisasi marang bathi mangsa ngarep|American Oncology Network (AONC) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep BGNE|Prakiraan rega marang bathi CKPT|Rega marang bathi mangsa ngarep ELEV|Pangali Forward P/E ICAD|Pangali Forward P/E Ikena Oncology Inc. (IKNA)|Pangali Forward P/E NTBL (Notable Labs Ltd)|Kapitalisasi marang proyeksi bathi Viracta Therapeutics (VIRX)|MOR: Prakiraan rega marang bathi|NAYA (NAYA Bio) - Rasio rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E